Veracity Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Hold |
7,414
| – | – | 0.08% | 203 |
|
|
2025
Q1 | $298K | Hold |
7,414
| – | – | 0.12% | 168 |
|
|
2024
Q4 | $349K | Hold |
7,414
| – | – | 0.13% | 155 |
|
|
2024
Q3 | $391K | Hold |
7,414
| – | – | 0.15% | 139 |
|
|
2024
Q2 | $402K | Sell |
7,414
-14
| -0.2% | -$759 | 0.17% | 125 |
|
|
2024
Q1 | $521K | Sell |
7,428
-50
| -0.7% | -$3.51K | 0.2% | 114 |
|
|
2023
Q4 | $624K | Buy |
7,478
+44
| +0.6% | +$3.67K | 0.25% | 87 |
|
|
2023
Q3 | $219K | Sell |
7,434
-72
| -1% | -$2.12K | 0.1% | 177 |
|
|
2023
Q2 | $245K | Buy |
7,506
+32
| +0.4% | +$1.04K | 0.1% | 187 |
|
|
2023
Q1 | $263K | Sell |
7,474
-34
| -0.5% | -$1.2K | 0.12% | 168 |
|
|
2022
Q4 | $344K | Buy |
7,508
+7
| +0.1% | +$321 | 0.16% | 131 |
|
|
2022
Q3 | $363K | Sell |
7,501
-820
| -10% | -$39.7K | 0.2% | 112 |
|
|
2022
Q2 | $327K | Hold |
8,321
| – | – | 0.17% | 130 |
|
|
2022
Q1 | $306K | Hold |
8,321
| – | – | 0.13% | 171 |
|
|
2021
Q4 | $379K | Hold |
8,321
| – | – | 0.15% | 147 |
|
|
2021
Q3 | $297K | Buy |
+8,321
| New | +$297K | 0.13% | 175 |
|
|
2021
Q2 | – | Sell |
-19,430
| Closed | -$452K | – | 245 |
|
|
2021
Q1 | $452K | Buy |
+19,430
| New | +$452K | 0.1% | 194 |
|